首页> 外文期刊>Mini-Reviews in Medicinal Chemistry >The Emergence of Selective 5-HT2B Antagonists Structures, Activities and Potential Therapeutic Applications [General Reviews]
【24h】

The Emergence of Selective 5-HT2B Antagonists Structures, Activities and Potential Therapeutic Applications [General Reviews]

机译:选择性5-HT 2B拮抗剂的结构,活性和潜在治疗应用的出现[一般评论]

获取原文
获取原文并翻译 | 示例
           

摘要

5-HT2 receptors mediate a large array of physiological and behavioral functions in humans via three distinct subtypes: 5-HT2A, 5-HT2B and 5-HT2C. While selective 5-HT2A antagonists have been known for some time, knowledge of the precise role played by the 5-HT2B receptor was hampered by the existence of solely 5- HT2B / 5-HT2C mixed antagonists.nnHowever, selective 5-HT2B antagonists began recently to emerge in the literature. Indeed, four structural classes belonging to the piperazine, indole, naphthylpyrimidine and tetrahydro-β-carboline scaffolds were reported. In this paper, we will briefly review the structural and pharmacological features of selective 5-HT2B antagonists, including patent literature of the last five years.
机译:5-HT2受体通过三种不同的亚型介导人类的多种生理和行为功能:5-HT2A,5-HT2B和5-HT2C。虽然选择性5-HT2A拮抗剂已经存在了一段时间,但仅存在5-HT2B / 5-HT2C混合拮抗剂阻碍了对5-HT2B受体发挥确切作用的了解。然而,选择性5-HT2B拮抗剂开始出现最近出现在文学中。实际上,已经报道了属于哌嗪,吲哚,萘基嘧啶和四氢-β-咔啉支架的四个结构类别。在本文中,我们将简要回顾选择性5-HT2B拮抗剂的结构和药理学特征,包括最近五年的专利文献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号